Pick the relation: C = C₀·e−kt, LD = Vd·C/(S·F), maintenance rate = CL·Css/(S·F), τ = ln(Cpeak/Ctrough)/k.
For kidney function, estimate CrCl with Cockcroft–Gault first, then scale the dose or the interval.
Check the result: levels fall by half every half-life, and steady state takes about five half-lives.
2Practice problems
1.PharmacologyMedium
Which lab tests are monitored in a patient taking carbamazepine?
ASerum amylase and lipase
BThyroid antibodies and cortisol
CFull blood count and serum sodium
DINR and aPTT
2.PharmacologyHard
Combining several drugs that prolong the QT interval raises the risk of which life-threatening arrhythmia?
AFirst-degree heart block
BSinus tachycardia
CTorsades de pointes
DAtrial fibrillation
3.Dosage calculationsMedium
A child weighing 18 kg is prescribed 4 mg/kg of a drug. The stock solution contains 10 mg/mL. Draw up the dose: what volume V do you give?
18 kg4 mg/kg10 mg/mL
V = mL
4.Dosage calculationsHard
The prescription is 1.78 mg. The ampoule contains 2000 micrograms per mL. Draw up the dose in the 1 mL syringe: what volume V do you give?
1.78 mg2000 mcg/mL
V = mL
5.Clinical pharmacokineticsMedium
Practice exercise (made-up values, not clinical guidance). After an IV dose of vancomycin, the level is 25 mg/L at 1 h and 12.5 mg/L at 7 h. Assume first-order elimination. Find the elimination rate constant k.
C1 = 25 mg/L (1 h)C2 = 12.5 mg/L (7 h)
k = h⁻¹
6.Clinical pharmacokineticsHard
Practice exercise (made-up values, not clinical guidance). A patient receives vancomycin IV every 12 h; the vancomycin clearance is 4 L/h. What dose D in mg gives an average steady-state level of 20 mg/L?
CL = 4 L/hτ = 12 hS = 1F = 1Css,avg = 20 mg/L
D = mg
3Solutions
1.Pharmacology
Answer: C · Full blood count and serum sodium
Why this is the answer
Carbamazepine can rarely cause bone marrow suppression and commonly lowers serum sodium. Blood counts, sodium and liver tests are checked, especially early in treatment.
Answer
C · Full blood count and serum sodium
2.Pharmacology
Answer: C · Torsades de pointes
Why this is the answer
A long QT interval delays repolarisation and can trigger torsades de pointes, which may turn into ventricular fibrillation. Drugs such as some macrolides, antipsychotics and antiarrhythmics add to this risk.
Answer
C · Torsades de pointes
3.Dosage calculations
Answer: V = 7.2 mL
Drawing up a dose: volume = (prescribed dose/stock strength) × stock volume. Convert to the same units first, then check that the volume fits the syringe and lands on one of its graduations.
Dose from body weight
D = 4·18 = 72 mg
Volume
V = 72/10 = 7.2 mL
On the syringe
On this 10 mL syringe every small line is 0.2 mL.
Answer
V = 7.2 mL
4.Dosage calculations
Answer: V = 0.89 mL
Drawing up a dose: volume = (prescribed dose/stock strength) × stock volume. Convert to the same units first, then check that the volume fits the syringe and lands on one of its graduations.
Same units
1.78 mg = 1780 mcg
Volume
V = 1780/2000 = 0.89 mL
Answer
V = 0.89 mL
5.Clinical pharmacokinetics
Answer: k = 0.1155 h⁻¹
Clearance and volume: at steady state the dosing rate equals the elimination rate, so the maintenance rate = CL × Css. A loading dose is LD = Vd × C/(S × F), with S the salt factor (fraction of active drug in the salt) and F the bioavailability (1 for IV). From two levels, k = ln(C₁/C₂)/Δt; for an IV bolus Vd = dose/C₀ and CL = k × Vd. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.
Elimination rate constant
k = ln(25/12.5)/6 = 0.6931/6 = 0.1155 h⁻¹
Answer
k = 0.1155 h⁻¹
6.Clinical pharmacokinetics
Answer: D = 960 mg
Designing a regimen: with rapid IV doses the level falls from peak to trough during the interval, so τ = ln(Cpeak/Ctrough)/k and the dose that restores the peak is Vd × (Cpeak − Ctrough). The average steady-state level is Css,avg = S·F·dose/(CL·τ). An infusion rises as C = (R/CL)(1 − e−kt). For a drug cleared by the kidneys, the dose is scaled with the creatinine clearance. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.